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Kallmann syndrome isa human genetic disorder characterized by the association of hypogonadism with theinability to smell, and is due to defects 
in the olfactory s stem development (i.e. incomplete migration of olfactory axons and of gonadotropin-releasing hormone producing neurons from 
the olfactory epithelium to the forebrain; aplasia or hypoplasia of olfactory bulbs and tracts). The human X-linked Kallmann syndrome gene and 
its chicken homologue have been cloned. Their protein products contain fibronectin type III repeats and a ‘four&sulfide-core domain also found 
in molecules that are involved in neural development. Consistent with the human phenotype, the chicken Kalhnann gene is expressed in the 
developing olfactory bulb. At present he molecular and cellular mechanism of action of the Kalhnann syndrome gene product is unknown. Based 
on expression studies and the characteristic domains of the predicted protein, it is hypothesized that the protein may be involved in targeting 
olfactory axons to the bulb. Alternatively, the Kalhnann protein could be an extracellular matrix component required for the proper formation 
of the multilayered structure of the olfactory bulb. 
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1. KALLMANN SYNDROME: PATHOGENESIS 
Nervous system development requires the formation 
of an intricate network of neuronal connections. Criti- 
cal steps in this process include the guided migration of 
neurons, axonal growth and targeting, reorganization 
of axonal and dendritic arbors, and cell death. Much of 
what is known about the molecules mediating neuronal 
migration and axonal targeting comes from in vitro 
experiments in which tissue environments have been 
reconstituted so that behavior of neurons and axons 
could be studied. A complementary approach, which 
has proved powerful in invertebrates, is the study of 
genetic mutants with specific neuronal defects [l]. An 
example of such a mutant in humans is X-linked Kall- 
mann syndrome, an inherited disease for which the gene 
has recently been isolated [2,3]. 
Kallmann syndrome is a human genetic disorder that 
occurs in X-linked, autosomal recessive and autosomal 
dominant forms [ 10,121. Phenotypically Kallmann syn- 
drome is defined by the association of anosmia (lack of 
the sense of smell) and hypogonadism [4]. Anosmia is 
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due to absence of olfactory bulbs and tracts [5], whereas 
the hypogonadism is hypothalamic in origin and caused 
by a deficiency of gonadotropin-releasing hormone 
(Gn-RH) [6]. In addition to hypogonadism and anos- 
mia, some individuals with Kallmann syndrome display 
synkinesia, eye movement abnormalities, cerebellar 
dysfunction, gaze-evoked horizontal nystagmus, pes 
cavus, unilateral renal agenesis and cleft palate [7-lo]. 
Note, some of these other symptoms are observed in 
genetically unrelated Kallmann patients carrying point 
mutations in the X-linked Kallmann syndrome gene, 
indicating that this gene has a more generalized role 
during development, involving both the nervous system 
and non-neuronal tissues [111. 
The pathogenetic basis underlying the association of 
anosmia and hypogonadism in Kallmann syndrome re- 
mained unexplained until a common developmental or- 
igin was recognized both for olfactory and Gn-RH se- 
creting neurons [13,14]. These neurons originate in the 
olfactory placode, a discrete thickening of the head ec- 
toderm which will later form the olfactory epithelium. 
From this peripheral ocation, olfactory neurons project 
their axons to the olfactory bulb where they form syn- 
apses with dendrites of mitral cells (Fig. 1). During 
development, Gn-RH neurons migrate along the olfac- 
tory, terminal and vomeronasal nerves (cranial nerve I 
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system) and across the olfactory bulb to eventually 
reach their definitive location in the hypothalamus 
[13,14]. Thus, Gn-RH neurons and olfactory axons 
share a common migration pathway. A remarkable fea- 
ture of olfactory neurons is that they have a half-life in 
the range of weeks and are replaced by new neurons that 
differentiate from a stem cell population present in the 
olfactory epithelium [15]. Therefore, migration and tar- 
geting of olfactory axons are required throughout life. 
Both axonal and neuronal migration are likely to be 
dependent on a number of guidance molecules. The 
evidence that one of these molecules is deficient in Kall- 
mann syndrome came from the histopathological analy- 
sis of a 19-week-old human fetus with X-linked Kall- 
mann syndrome [16]. In this fetus, olfactory axons de- 
veloped normally and started their migration towards 
the forebrain, but arrested prematurely in the meninges 
between the cribriform plate and the forebrain. Further- 
more, Gn-RH producing neurons of this fetus ended 
their migration at the dorsal surface of the cribriform 
plate. Based on these findings it has been proposed that 
the X-linked Kallmann syndrome gene (KAL) encodes 
a factor involved in migration of olfactory axons and 
Gn-RH neurons [16]. 
2. X-LINKED KALLMANN SYNDROME: GENE 
CLONING AND CHARACTERIZATION 
The first mapping assignment of a locus for X-linked 
Kallmann syndrome came from the clinical observation 
of a family in which several affected males had a com- 
plex phenotype characterized by Kallmann syndrome 
associated to X-linked ichthyosis, due to steroid sulfa- 
tase (STS) deficiency [17]. It was postulated that these 
patients had a contiguous gene syndrome due to the 
co-deletion of two contiguous genes, the KAL and the 
STS genes, on the X-chromosome. Therefore, KAL was 
assigned to Xp22.3, close to the STS gene [17]. Since 
then, several patients with Xp22.3 rearrangements and 
contiguous gene syndromes have been described [18], 
leading to the construction of a deletion map of the 
Xp22.3 region and to the assignment of KAL to a spe- 
cific deletion interval within this map. From this inter- 
val, in which at least a part of the gene had to be located, 
two groups independently isolated the same candidate 
gene for X-linked Kallmann syndrome by positional 
cloning, using different strategies [2,3]. The identity of 
this gene has since then been confirmed by the identifi- 
cation of patients with Kalhnann syndrome who carry 
intragenic deletions and point mutations [ 11,191. 
in a large region of X/Y homology on Xp22.3 and 
Yql 1.2 respectively. In a patient with Kallmann syn- 
drome, abnormal pairing and precise recombination be- 
tween the X-linked KAL gene and its Y homologue 
resulted in an X/Y translocation creating a fusion Kall- 
mann syndrome gene containing the entire KAL-X gene 
with the exception of the last exon and part of the last 
intron, which derived from the KAL-Y gene [22] (Fig. 
2A). Both the last splice junction and the stop codon 
sequences of the fusion gene are identical to those of the 
normal KAL-X gene. However, the transcription and/ 
or the stability of the mRNA are affected by the translo- 
cation. This might imply that the 3’ portion of the KAL- 
X gene has functional importance and cannot be substi- 
tuted by the corresponding region of the KAL gene on 
the Y chromosome. 
3. THE KAL PROTEIN 
Sequence analysis of the predicted protein product of 
KAL revealed the presence of several features sugges- 
tive of a function in neural development. KAL encodes 
a protein of 680 amino acids which contains an amino 
terminal signal peptide and lacks a transmembrane do- 
main or a putative phosphatidyl-inositol linkage site. 
These data suggest that KAL protein is probably 
secreted. 
Characterization of the KAL structure revealed the The KAL protein contains a ‘four-disulftde-core’ do- 
presence of 14 exons spanning approximately 210 kb on main, characterized by eight conserved cysteines form- 
Xp22.3 [20,21]. The gene was proved to escape X-inac- ing four disulfide bonds (Fig. 2B). ‘Four-disulfide-core’ 
tivation (i.e. it is expressed both by the active and by the is a compact fold found in a number of proteins such 
inactive X chromosome) and to have a closely related as wheat germ agglutinin, neurotoxins and protease in- 
but nonfunctional homologue on the Y chromosome hibitors [23-281. All known proteases inhibited by pro- 
[20,21]. The X and Y copies of the KAL gene are located teins containing the ‘four-disulfide-core’ motif are solu- 
Fig. 1. The olfactory system in human. (left) Olfactory neurons possess 
odorant receptors and lie in the olfactory epithelium that is located in 
the dorsal posterior recess of the nasal cavity. The olfactory bulb, part 
of the forebrain, is a small flattened body that rests on the cribriform 
plate. (right) Axons of the olfactory neurons project through foramina 
of the cribriform plate to the olfactory bulb and form synapses with 
mitral cell dendrites in specialized areas called the glomeruli. The 
axons of mitral cells project to the olfactory cortex. Interneurons that 
modify the olfactory input within the bulb are not depicted. 
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Fig. 2. (A) The X and Y copies of the X-linked Kallmann syndrome gene (KAL) and the steroid sulfatase gene (STS) are located in a large region 
of X/Y homology on Xp22.3 and Yqll.2, respectively, as indicated. The X copy of KAL is functional but not the Y copy. Abnormal pairing and 
precise recombination between the X copy of KAL and its Y homologue resulted in a XN translocation, t(X;Y), creating a fusion Kallmann 
syndrome gene which is nonfunctional. (B) Schematic representation of the KAL protein structure. The position of the ‘four-disullide-core’ domain 
(4 Cys,) and of fibronectin type III repeats (FN III) are indicated by boxes. The open box at the N-terminus represents the putative signal peptide. 
ble serine proteases. However, since neurotoxins and 
wheat germ agglutinin evidently interact with mem- 
brane-bound receptors, it is possible that the ‘four-di- 
sulfide-core’ fold could interact with yet to be identified 
serine proteases located on the cell surface. Examples of 
proteases associated with the cell membrane are plas- 
minogen activator-like proteases that have specific bind- 
ing sites on a variety of neurons and are believed to 
regulate growth cone adhesion to specific matrix com- 
ponents, thus facilitating axonal elongation [29-3 11. 
The carboxy terminal two thirds of the protein con- 
tains two domains that show similarities with the fi- 
bronectin type III repeat (Fig. 2B), first detected in 
fibronectin, an extracellular matrix adhesion molecule. 
Fibronectin type III repeats also occur in many neural 
cell adhesion molecules [32], and in receptor-linked pro- 
tein kinases and phosphatases [33]. Transmembrane- or 
phosphatidyl-inositol-anchored cell adhesion molecules 
and also extracellular matrix proteins with fibronectin 
type III repeats such as fibronectin and tenascin have 
been implicated in neuronal migration and axonal 
growth and guidance [34-391. Although the specific 
function of fibronectin type III repeats in these mole- 
cules is not yet completely understood, the presence of 
fibronectin type III repeats seems to influence axonal 
outgrowth. For example, a 33 kDa fibronectin type III 
130 
repeat-containing fragment of fibronectin is capable of 
specifically interacting with chick spinal cord-, sensory-, 
and sympathetic neurons [40]. 
In conclusion, although KAL protein shares similari- 
ties with molecules clearly involved in neural develop- 
ment, it displays some original features, such as the 
combination of a protease inhibitor domain with sub- 
strate adhesion function. 
4. EVOLUTIONARY ASPECTS OF THE 
X-LINKED KALLMANN SYNDROME GENE 
Evolutionary studies of the Kallmann syndrome gene 
performed by ‘zoo’ blot analysis revealed sequence con- 
servation among several species, including monkey, 
cow, rabbit, sheep, chicken, but interestingly, not 
mouse. This analysis demonstrated that the Kallmann 
syndrome gene has largely been conserved over - 200 
million years, the evolutionary distance that separates 
birds from mammals. The chicken homologue of KAL 
has been isolated [41], and has an overall protein se- 
quence identity with the human gene of 77%. Sequence 
identity between the avian and human KAL gene pro- 
tein products ranges between 91% and 94% within the 
‘four-disulfide-core’ and the fibronectin type III re- 
peats, emphasizing their functional importance. An- 
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other feature common to both avian and human pro- 
teins is the hydrophobic character of the amino termi- 
nus which further supports the idea that the Kallmann 
syndrome gene product is probably secreted. 
In view of the high degree of homology between the 
human and the chicken genes, it is intriguing that low 
stringency Southern blot analysis, screening of cDNA 
libraries and PCR-based approaches using degenerate 
oligonucleotides have so far failed to identify any se- 
quence homologous to the Kallmann syndrome gene in 
the mouse (A.B., unpublished data). This lack of ho- 
mology with the mouse seems to be a peculiarity of the 
Xp22.3 region of the X chromosome in which the Kall- 
mann syndrome gene is located. For most of the human 
genes isolated from this region, a murine homologue 
has not been found. One explanation is that this region 
has been lost in the mouse during evolution. Since olfac- 
tory system development is very similar in primates, 
other mammals, birds and even amphibians [15], a mol- 
ecule clearly required for development of the olfactory 
bulb in man ought to be present in mice. Therefore, we 
favor two alternative explanations: either mice contain 
a gene extremely divergent from the human and avian 
counterparts, or mice have evolved a compensating 
pathway. 
5. EXPRESSION PATTERN OF KAL AND RELA- 
TION TO THE HUMAN PHENOTYPE 
There is only limited information on the expression 
of KAL in human tissues. Reverse transcriptase-PCR 
studies showed the presence of KAL mRNA in 1% 
week-old fetal and in adult human tissues, including 
brain, muscle, kidney, and liver [2,3]. KAL transcripts 
were also found in the embryonal carcinoma cell line 
NT2/Dl and in a lymphoblastoid cell line [3]. These 
data indicate that the KAL gene may be widely ex- 
pressed in human tissues, including neuronal and non- 
neuronal cell types. This finding is consistent with the 
fact that patients with Kallmann syndrome exhibit a 
variety of neurological and non-neurological symptoms 
[411]. 
Detailed expression studies are not practical in 
human embryos. Therefore, the chicken homologue of 
the KAL gene was isolated and its spatiotemporal ex- 
pression pattern in chick embryos examined using in 
situ hybridization [41]. Since the basic mechanisms of 
the development of the olfactory system are very similar 
in mammals and birds, the pattern of KAL expression 
in the olfactory system of chick is likely to be helpful in 
understanding the cause of anosmia in Kallmann syn- 
drome. Expression of the KAL gene was not above 
background levels during the early phase of olfactory 
system development. No KAL mRNA was detected at 
the time when the olfactory placode differentiates into 
the olfactory epithelium to form olfactory neurons and 
Gn-RH producing neurons. Likewise, expression was 
not detectable by in situ hybridization in the neuroep 
ithelium of the presumptive bulb region, when olfactory 
axons first reach the forebrain. However, when the neu- 
roepithelium of the presumptive olfactory bulb begins 
to differentiate and to give rise to postmitotic mitral cell 
precursors, the KAL gene begins to be expressed in 
these precursors (Fig. 3A). As the bulb acquires its char- 
acteristic laminar structure, KAL transcript levels fur- 
ther increase in the mitral cells (Fig. 3B-D), and the 
expression in mitral cells persists throughout life. Since 
KAL is not expressed in the olfactory epithelium (Fig. 
3E) or in the mesenchymal tissue between the epithe- 
lium and the bulb region, it appears that KAL is not 
directly required for guiding olfactory axons from the 
olfactory epithelium towards the presumptive olfactory 
bulb in the forebrain region nor is it needed for the 
establishment of initial contacts between the olfactory 
axons and the olfactory bulb. Rather it is necessary for 
later processes in the developing olfactory bulb, such as 
for histogenesis of the bulb and/or for the establishment 
and maintenance of proper interactions between olfac- 
tory axons and dendrites of mitral cells (see below). 
The expression pattern of KAL in the chicken olfac- 
tory bulb is consistent with the observed defects in pa- 
tients with Kallmann syndrome. First, Kallmann syn- 
drome patients have aplasia or hypoplasia of the olfac- 
tory bulb [5,42], indicating that the KAL gene is essen- 
tial for bulb development. Second, it was found that the 
olfactory epithelium of a lPweek-old human fetus with 
Kallmann syndrome differentiated normally, and that 
in this fetus the olfactory nerves projected axons to the 
forebrain [16]. However, instead of contacting the fore- 
brain neuroepithelium, the axons stopped within the 
meninges. Furthermore, in the same fetus, Gn-RH neu- 
rons differentiated normally and migrated along the 
cranial nerve I system, but arrested their migration at 
the distal end of these nerves to accumulate in the me- 
ninges [16]. This analysis of the Kallmann syndrome 
fetus suggests that development and migration of olfac- 
tory axons and Gn-RH neurons do not directly require 
the KAL gene. This interpretation is supported by the 
expression studies in chicken: the in situ hybridization 
data demonstrate that olfactory neurons, Gn-RH neu- 
rons and mesenchymal tissue through which these neu- 
rons migrate do not express the KAL gene. To further 
substantiate the correlation between the in situ hybridi- 
zation data in chick and the human phenotype, it re- 
mains to be demonstrated that KAL gene is also ex- 
pressed in the human olfactory bulb. 
The examination of patients with Kalhnann syn- 
drome reveals that there are various defects outside the 
olfactory system [8-l 11. Consistent with this, high level 
of KAL expression was found in areas outside the olfac- 
tory system of the chick [41]. However, since it is not yet 
understood how and when in human development these 
defects appear, the correlation of these sites of KAL 
expression in chick with the human phenotype is not as 
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straightforward as it is in the case of the olfactory sys- 
tem. KAL expression found in the oculomotor nucleus 
[41] might relate to eye movement abnormalities een in 
Kalhnann patients [8], since neurons from the oculomo- 
tor nucleus innervate extrinsic eye muscles. KAL ex- 
pression in the Purkinje cells of the cerebellar cortex [41] 
might relate to ataxia (abnormalities of coordinated 
movement), and pes cavus in Kallmann patients [8] 
might correlate with KAL expression in the developing 
limb buds [41]. Other sites of expression, such as the 
nasal cartilage (Fig. 3E) and the retina (Fig. 3F), do not 
appear to correlate with known defects in patients with 
Kallmann syndrome. A possible explanation for this 
observation is that in these tissues there are compensa- 
tory pathways in humans. Accordingly, the lack of the 
KAL gene does not result in detectable defects. An 
alternative possibility is that in these tissues the KAL 
gene is not expressed in humans. 
As pointed out, KAL mRNA is also found in non- 
neuronal tissues such as facial mesenchyme, developing 
limb buds [41] and cartilage (Fig. 3E). It is well known 
that cell migration, cell adhesion and establishment of 
specific cell contacts required for nervous system devel- 
opment have counterparts in non-neuronal tissues [39]. 
An example of a protein involved in neuronal interac- 
tions but also expressed in non-neuronal tissues is F- 
spondin [43]. This potein promotes neural cell adhesion 
and neurite outgrowth and is expressed at high levels in 
the floor plate, the ventral part of the developing spinal 
cord. In addition, F-spondin is also expressed in embry- 
onic kidney, lung, and cartilage, tissues whose develop- 
ment also require cell adhesion [43]. 
In conclusion, chick appears to be an appropriate 
model system to study the cellular basis of the Kall- 
mann syndrome, as the in situ hybridization data on 
chicken embryos [41] are consistent with many of the 
defects seen in patients with Kallmann syndrome. 
6. POSSIBLE BIOCHEMICAL FUNCTION OF 
THE KAL GENE IN THE OLFACTORY BULB 
mRNA distribution studies in the chick embryo indi- 
cate that KAL gene function is not directly required in 
the initial migration of olfactory axons and Gn-RH 
neurons. This raises the question of the role of this gene 
in the olfactory system. At the present time, it is not 
precisely known where the KAL gene product is located 
within the olfactory bulb. However, the sequence of the 
KAL protein suggests that the KAL protein is secreted 
and, therefore, may be found in the extracellular matrix. 
If this is the case, several and perhaps parallel roles of 
KAL can be envisaged in the olfactory bulb. (i) KAL 
protein could be a structural protein required for the 
development and maintenance of the architecture of the 
bulb. This would explain why the bulb fails to develop 
in Kallmann syndrome patients. (ii) KAL protein could 
be a substrate adhesion molecule mediating the interac- 
tion of the mitral cell dendrites with olfactory axons. 
The presence of fibronectin type III repeats in the KAL 
protein support such a hypothesis, since cell adhesion 
molecules and extracellular matrix proteins containing 
fibronectin type III repeats are thought to play a role 
in neuronal migration and axonal growth and guidance 
[34,35,39]. In the case of the KAL protein the two fi- 
bronectin type III repeats could bind to cell surface 
receptors, possibly integrins located on the growth 
cones of olfactory axons. (iii) The ‘four-disulfide-core’ 
is also found in a variety of neurotoxins [23] capable of 
binding to ion channels. Accordingly, in the case of the 
KAL protein, the ‘four-disulfide-core’ could interact 
with receptors located on e.g. growth cones of olfactory 
axons. (iv) Monard [30] proposed that a balance be- 
tween protease and protease-inhibitor activities may 
regulate neurite outgrowth. The ‘four-disulfide-core’, a 
putative protease inhibitor domain, might bind to pro- 
teases ecreted by olfactory axons and this would regu- 
late the proteolytic actions of olfactory axons. (v) Olfac- 
tory neurons are continuously replaced from stem cells 
in the olfactory epithelium and grow new axons to the 
bulb. Therefore, the synaptic connections in the glomer- 
uli are continuously remodeled. Given the persistent 
expression of KAL throughout life, it is tempting to 
speculate that this protein is engaged in establishing and 
maintaining axodendritic interactions along the lines 
discussed above in point (ii), (iii) and (iv). Plasticity, 
although to a lesser degree, has been observed in the 
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Fig. 3. Expression of the chicken KAL gene revealed by in situ hybridization. Micrographs are double exposures, the red color represents the m 
situ hybridization signal, and the blue color shows the nuclei stained with Hoechst 33258 dye. (A) shows a transverse section through the head 
of a 7-day-old chick embryo. KAL is expressed in the rostra1 part of the forebrain (white arrow) where olfactory nerves (asterisk) contact the region 
of the brain from which the olfactory bulb will develop. The KAL-positive cells are postmitotic mitral cell precursors. (B) is a transverse section 
through the olfactory bulb of a lo-day-old chick embryo. Note the high KAL expression in the mitral cell layer. (C) shows a transverse section 
through part of the olfactory bulb of a newly hatched chicken (21 days), and (D) displays a neighboring section stained with thionin to demonstrate 
that the KAL-positive area in (C) corresponds to the mitral cell layer. Note that mitral cells have large cell bodies (black arrow). (E) is a frontal 
section through the head of a 7-day-old chick embryo, showing that the olfactory epithelium is KAL-negative. Note high levels of KAL expression 
m the nasal cartilage and the uniformly low expression in the developing retina. The signal overlaying the pigment epithelium is artefactual due 
to pigment granules. (F) shows a section through the retina of a 9-day-old chick embryo. KAL mRNA is concentrated in the presumptive inner 
nuclear layer which contains interneurons but no primary sensory neurons. Note that at this time of development migration and redistribution 
of differentiating neuroblasts is still ongoing. Abbreviations: c, nasal cartilage; e, ependymal layer; gl, glomerular layer; grl, granule cell layer; inl, 
presumptive inner nuclear layer; ml, mitral cell layer; oe, olfactory epithelium; pe, pigment epithelium; re, retina; v, lateral ventricle. Magnificattons 
in (A), (B), and (E) are identical, and (C), (D), and (F) are on the same scale. Bars, 500 pm (E); 100 PM (F). 
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cerebellum, where changes in the number and pattern 
of synapses of Purkinje cells are part of cerebellar corti- 
cal motor learning [44]. In chicken, KAL is expressed 
in the Purkinje cells of embryonic and adult cerebellum, 
supporting a role of KAL in some aspects of synapse 
formation. It should be emphasized that the various 
biochemical modes of action we discuss are not mutu- 
ally exclusive. For example, in early development he 
KAL gene product could be involved in establishing the 
structural integrity of the developing bulb and in the 
formation of axodendritic interactions. Later, during 
adult life, KAL function could be restricted just to the 
second process. In order to further examine the pro- 
posed ,functions of the KAL gene product, it will be 
important to localize the KAL protein and to develop 
in vitro systems in which KAL function can be studied. 
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